In a prospective, placebo-controlled, one group crossover design study, we tested whether adding programmed intracavernous PGE1 injections (IC-PGE1) can improve the effectiveness of sildenafil in ...
A 46-year-old man with type II diabetes, hypertension and dyslipidaemia and a 4-year history of erectile dysfunction, presented with a painful priapism 7 h following the administration of oral ...
Background. In March 2002, a patient in Tel Aviv, Israel, died of endocarditis caused by Phialemonium curvatum. As part of his therapy for erectile dysfunction, the patient had been trained to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results